In this episode, Sally Ann Frank, Global Lead for Health and Life Sciences at Microsoft for Startups, discusses how AI is moving beyond experimentation toward measurable enterprise impact. She emphasizes that the most successful startups differentiate themselves not just through technology innovation, but through evolving business models, strong customer discovery practices, and a coachable mindset grounded in strategic mentorship.
Sally explores the challenge of “pilot purgatory,” noting that founders must design for production from day one. Establishing clear ROI frameworks and demonstrating early value are essential to maintaining momentum and avoiding the law of diminishing interest often seen in stalled pilots. Looking toward 2026, Sally envisions a “show me the money” era centered on four bridges: expanding global access through virtual technology to democratize care, closing the investment gap in women’s health beyond reproductive care, advancing AI-driven precision medicine through genetics for individualized treatment, and shifting healthcare from reactive treatment toward preventative longevity. Ultimately, the conversation highlights that lasting success in AI will belong to organizations that evolve into trusted advisors, consistently delivering value at every interaction. Take a listen.
This guest appearance was facilitated through conversations initiated at HIMSS.
In this episode, Tanya Townsend, CEO of LCMC Health, a New Orleans-based non-profit health system, discusses how they are leveraging their digital capabilities across...
In this episode, Karen Murphy discusses her role as the first Chief Innovation Officer and the Founding Director of the Steele Institute for Health...
In this episode, Zane Burke, CEO of Quantum Health discusses the current state of digital health and how Quantum is working towards creating a...